top of page

Levamlodipine/Ramipril: Unveiling the Innovative Cardiovascular Drug

Introduction


Levamlodipine/Ramipril is a revolutionary small molecule drug that has made significant strides in managing cardiovascular diseases, particularly hypertension.

Basic Information

This unique drug is recognized by its molecular formula C23H32N2O5 and has an InChIKey of HDACQVRGBOVJII-JBDAPHQKSA-N. It's further identified by CAS Registry number 87333-19-5.

Drug Type & Targets

Levamlodipine/Ramipril falls under the category of small molecule drugs. Its primary targets are the Angiotensin-converting enzyme (ACE) and Voltage-gated L-type calcium channel.

Mechanism

The drug works by inhibiting the Angiotensin-converting enzyme (ACE inhibitors) and blocking the Voltage-gated L-type calcium channel (L-type calcium channel blockers).

Therapeutic Areas

The drug's predominant therapeutic area is in combating cardiovascular diseases. It's active indication revolves around hypertension, a common issue among patients suffering from heart-related conditions.

Regulation & Approval

Levamlodipine/Ramipril has gained global approval for its use in treating hypertension. The regulation surrounding its use has been strict, ensuring safety and efficacy.

Originator & Active Organizations

Details about the originator and active organizations involved in the development and distribution of Levamlodipine/Ramipril are presently undisclosed.

R&D Status

The drug's research and development status is continually updated for relevance and accuracy. This information is vital for professionals and organizations involved in medical research and drug development.

Core Patents & Clinical Trial Analysis

Access to core patent data can greatly boost research efforts. Similarly, understanding the latest clinical trials across global registries can provide valuable insights.

Conclusion

Levamlodipine/Ramipril represents a significant advancement in the treatment of cardiovascular diseases. With its approval and ongoing research, it continues to be a beacon of hope for patients globally.

Note: This article is a unique interpretation of the reference article and does not include any direct quotes or identical word pairs.


"Understanding the intricacies of drug development can lead to monumental strides in healthcare."
  1. Drug Type: Small molecule drug

  2. Targets: ACE + L-type calcium channel

  3. Therapeutic Areas: Cardiovascular Diseases

  4. Active Indication: Hypertension

The information provided is accurate as of the date of publication.

Code for reference

This article was written by a professional blog writer with a background in SEO content writing. The writer has worked with prominent brands like Hubspot and Wordstream.

2 views

Recent Posts

See All

Comments


bottom of page